Fondaparinux Subcutaneous and Hepatic impairment
Result of checking the interaction of drug Fondaparinux Subcutaneous and disease Hepatic impairment for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:In general, the manufacturer recommends avoiding the use of factor Xa inhibitors in patients with moderate and severe hepatic impairment or with any hepatic disease associated with coagulopathy as drug exposure and bleeding risk may be increased.
Generic Name: fondaparinux
Brand Name: Arixtra, Arixtra 5 mg/dose, Arixtra 75 mg/dose, Arixtra 10 mg/dose
Synonyms: Fondaparinux
Fondaparinux Subcutaneous - zaburzenia czynności wątroby 
Fondaparinux Subcutaneous - insuficiência hepática 
Fondaparinux Subcutaneous - gangguan hati 
Fondaparinux Subcutaneous - gangguan hati 
Fondaparinux Subcutaneous - insufficienza epatica 
Fondaparinux Subcutaneous - insuffisance hépatique 
Fondaparinux Subcutaneous - Leberfunktionsstörung 
Fondaparinux Subcutaneous - deterioro hepático 
Fondaparinux Subcutaneous - печеночная недостаточность 
Fondaparinux Subcutaneous - karaciğer yetmezliği 
Fondaparinux Subcutaneous - اختلال كبدي 
Fondaparinux Subcutaneous - 肝功能不全